AbbVie's Neuroscience Portfolio Projected to Generate $12.7 Billion in Revenue by 2026
AbbVie, a pharmaceutical giant known for its immunology products like Humira and newer blockbusters Skyrizi and Rinvoq, is seeing significant growth in its neuroscience division. The company's neuroscience portfolio, whi